Neolife SA (ALNLF) Stock Price & News

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	3.37M	3.37M	3.32M	3.32M
Cost of goods sold	1.63M	1.63M	2.59M	2.59M
Cost of revenue	1.63M	1.63M	2.59M	2.59M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-636.44K	-636.44K	731.54K	731.54K
Operating expense	1.69M	1.69M	944.30K	944.30K
Total operating expenses	3.33M	3.33M	3.54M	3.54M
Operating income	41.85K	41.85K	-218.89K	-218.89K
Other non operating income	-1.00	-1.00	13.20K	13.20K
EBT including unusual items	42.80K	42.80K	-222.61K	-222.61K
EBT excluding unusual items	32.71K	32.71K	-222.61K	-222.61K
Income tax expense	-39.50K	-39.50K	-20.00K	-20.00K
Effective tax rate	-92.28%	-92.28%	8.98%	8.98%
Other operating expenses	2.50M	2.50M	25.39K	25.39K
Net income	82.30K	82.30K	-202.61K	-202.61K
Net profit margin	2.44%	2.44%	-6.10%	-6.10%
Earnings per share	-	-	-	-
Interest and investment income	-	-	418.00	418.00
Interest expense	-9.15K	-9.15K	-17.33K	-17.33K
Net interest expenses	-9.15K	-9.15K	-16.92K	-16.92K
Depreciation and amortization charges	-171.05K	-171.05K	187.38K	187.38K
EBITDA	210.35K	210.35K	-49.14K	-49.14K
Gain or loss from assets sale	-	-	-	-

Finance